Future Oncol. 2015;11(1):91-106. Abiraterone was investigated in Phase I/II study in chemotherapy-naive CRPC patients: in this trial, a decline in PSA of ≥50% was observed in 67% of patients, a ...

and it feels like these ideas about optimization and macros and an obsession with protein have gone — forgive the obvious metaphor — on steroids. There's real science behind how getting more ...

Some people are at higher risk of more severe disease or outcomes from COVID-19 infection than others. However, COVID-19 vaccines help reduce the risks of severe illness, hospitalization and death ...